New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Patients with PAD who meet criteria for frailty can reap similar benefits as their nonfrail counterparts when prescribed a combination of low-dose direct oral anticoagulant and aspirin following lower extremity revascularization, an analysis of the VOYAGER-PAD trial shows.